Search by Drug Name or NDC
NDC 70954-0258-10 Sulfamethoxazole and Trimethoprim 200; 40 mg/5mL; mg/5mL Details
Sulfamethoxazole and Trimethoprim 200; 40 mg/5mL; mg/5mL
Sulfamethoxazole and Trimethoprim is a ORAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ANI Pharmaceuticals, Inc.. The primary component is SULFAMETHOXAZOLE; TRIMETHOPRIM.
MedlinePlus Drug Summary
Co-trimoxazole is used to treat certain bacterial infections, such as pneumonia (a lung infection), bronchitis (infection of the tubes leading to the lungs), and infections of the urinary tract, ears, and intestines. It also is used to treat 'travelers' diarrhea. Co-trimoxazole is a combination of trimethoprim and sulfamethoxazole and is in a class of medications called sulfonamides. It works by stopping the growth of bacteria. Antibiotics will not kill viruses that can cause colds, flu, or other viral infections.
Related Packages: 70954-0258-10Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Co-trimoxazole
Product Information
| NDC | 70954-0258 |
|---|---|
| Product ID | 70954-258_87d97c06-8323-488f-b75b-009c8840c411 |
| Associated GPIs | 16990002301810 |
| GCN Sequence Number | 009394 |
| GCN Sequence Number Description | sulfamethoxazole/trimethoprim ORAL SUSP 200-40MG/5 ORAL |
| HIC3 | W2A |
| HIC3 Description | ABSORBABLE SULFONAMIDE ANTIBACTERIAL AGENTS |
| GCN | 90150 |
| HICL Sequence Number | 004071 |
| HICL Sequence Number Description | SULFAMETHOXAZOLE/TRIMETHOPRIM |
| Brand/Generic | Generic |
| Proprietary Name | Sulfamethoxazole and Trimethoprim |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Sulfamethoxazole and Trimethoprim |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SUSPENSION |
| Route | ORAL |
| Active Ingredient Strength | 200; 40 |
| Active Ingredient Units | mg/5mL; mg/5mL |
| Substance Name | SULFAMETHOXAZOLE; TRIMETHOPRIM |
| Labeler Name | ANI Pharmaceuticals, Inc. |
| Pharmaceutical Class | Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Su |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA214330 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70954-0258-10 (70954025810)
| NDC Package Code | 70954-258-10 |
|---|---|
| Billing NDC | 70954025810 |
| Package | 473 mL in 1 BOTTLE (70954-258-10) |
| Marketing Start Date | 2022-02-08 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.06097 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | SULFAMETHOXAZOLE-TMP SUSP |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis